Association between tumor volume reduction and treatment outcomes in nasopharyngeal carcinoma treated with PCE-based induction chemotherapy and concurrent chemoradiotherapy.
Oct 2026· International Journal of Clinical Oncology· 0 citations· 20 references
Medicine
TL;DR
VRR was associated with PFS, suggesting that tumor shrinkage following IC-PCE may serve as a prognostic marker in patients with locoregional advanced nasopharyngeal carcinoma.
OBJECTIVE
To evaluate the impact of diagnosis-to-treatment interval (DTI) and radiotherapy interval (RTI) on overall survival (OS) in locally advanced nasopharyngeal carcinoma (LA-NPC) treated with concurrent chemoradiotherapy (CCRT).
STUDY DESIGN
Retrospective database study.
SETTINGS
Single tertiary academic cent...
E. Topkan, E. Somay, S. Başçıl et al.· Otolaryngology Head & Neck S...· 0 citations
Background De novo metastatic nasopharyngeal carcinoma (mNPC) carries a poor prognosis with systemic therapy alone. Locoregional radiotherapy (LRRT) improves survival in chemotherapy-responsive patients, but the incremental role of metastasis-directed therapy (MDT) remains undefined. Methods This retrospective cohort i...
S. Ghosh-Laskar, Anuj Kumar, R. Malhotra et al.· Clinical and Translational R...· 0 citations
Background Chemoimmunotherapy has become the standard first-line treatment for de novo metastatic nasopharyngeal carcinoma (dmNPC). However, the role and optimal timing of locoregional radiotherapy in dmNPC in the chemoimmunotherapy era remain unclear. This study aims to evaluate whether salvage locoregional radiothera...
Real-world evidence on concomitant chemoradiotherapy (CCRT) for head and neck squamous cell carcinoma (HNSCC) in Bosnia and Herzegovina remains limited. We aimed to characterize treatment delivery, toxicity, and survival and identify modifiable barriers to optimal care. This retrospective single-institution cohort stud...
Gordana Berić Jozić, M. Mabić, Monika Glibić et al.· Biomolecules & biomedicine· 0 citations
698
Background:
Bladder-preserving chemoradiotherapy is an established treatment option for selected patients with muscle-invasive bladder cancer (MIBC). This study evaluated survival outcomes, toxicities, and prognostic factors in patients treated with definitive radiotherapy with or without concurrent chemoth...